First quarter 2022 sales increased 25 percent to $175.9 million compared to the same period of 2021.
Revenue of $5.0 billion increased 2.1% as reported and 3.9% on currency-neutral basis.
Management will host a conference call and webcast to provide a business update at 8:30 a.m. Eastern Time on Friday, May 13, 2022.
One Drop, a leader in precision health solutions for people living with diabetes and other chronic conditions, today announced that it has been named Best Personal Health App in the 2022 MedTech Breakthrough Awards Program, which recognizes outstanding health and medical technology products and companies.
#mobile app
MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that Welldoc®, a digital health leader revolutionizing chronic care, has been selected as winner of the “Best Overall Connected Healthcare Solution” award in the sixth annual MedTech Breakthrough Awards program.
#mobile app
#coaching
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Shacey Petrovic has decided to step down from her position as President and Chief Executive Officer (CEO) of Insulet for personal family reasons, effective June 1, 2022. Effective June 1, 2022, Jim Hollingshead, Ph.D. will succeed Ms. Petrovic as Insulet’s President and CEO.
cobas® pulse is a point-of-care blood glucose (BG) measuring system for multiple-patient use in professional healthcare settings. The system provides advances in connectivity and BG measuring technology, and has multiple fail-safes to improve accuracy and reduce the risk of user error.
#bgm
First quarter 2022 revenue of $295.4 million, up 17.1%, or 19.3% in constant currency, compared to $252.3 million in the prior year, exceeds the guidance range of 13% to 16% in constant currency.
The study analyzed the effectiveness of a free app linked to a glucose meter to study reductions in glucose levels over time among a self-selected sample of adults with T2D.
#mobile app
#bgm
The study examines the impact of real-time continuous glucose monitoring (rtCGM) on psychosocial outcomes in adults with insulin-using type 2 diabetes (T2D).
#cgm